Press Announcements > FDA and NRC pave way for the first domestic supply of the most commonly used medical isotope in diagnostic imaging

Press Announcements > FDA and NRC pave way for the first domestic supply of the most commonly used medical isotope in diagnostic imaging

FDA and NRC pave way for the first domestic supply of the most commonly used medical isotope in diagnostic imaging

The U.S. Food and Drug Administration and the Nuclear Regulatory Commission (NRC) today took steps to ensure a stable and secure supply of a critical radioactive imaging product used to detect potentially life-threatening diseases. The FDA approved the RadioGenix System, a unique system for producing Technetium-99m (Tc-99m), the most widely used radioisotope in medical imaging. The NRC is issuing guidance and will license the RadioGenix System to enable the Tc-99m it produces to be used for its medical purpose. Continue reading.